EXIT-RIF: Evaluating the Xpert Impact on Tuberculosis – RIFampicin Resistance. EXIT-RIF
收藏NIAID Data Ecosystem2026-03-14 收录
下载链接：
https://www.ncbi.nlm.nih.gov/bioproject/PRJEB57923
下载链接
链接失效反馈官方服务：
资源简介：
EXIT-RIF is a before/after cohort study comparing treatment outcomes of patients diagnosed with rifampicin resistant TB by Xpert MTB/RIF or culture-based susceptibility method. The study started in February 2012.
创建时间：
2022-12-02
